Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion

Journal of Diabetes Investigation

Volumn 5, Issue 1, 2014, Pages 48-50

  Nakamura, Tomoaki ^a   Hirota, Yushi ^a   Hashimoto, Naoko ^a   Matsuda, Tomokazu ^a   Takabe, Michinori ^a   Sakaguchi, Kazuhiko ^a   Ogawa, Wataru ^a   Seino, Susumu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbohydrate insulin ratio; Continuous subcutaneous insulin infusion; Type 1 diabetes mellitus

Indexed keywords

INSULIN;

ADULT; ARTICLE; CARBOHYDRATE TO INSULIN RATIO; CIRCADIAN RHYTHM; CONTINUOUS INFUSION; DIABETIC PATIENT; FEMALE; HOSPITAL PATIENT; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; JAPANESE; MALE; MEAL; METABOLIC PARAMETERS; PRIORITY JOURNAL;

EID: 84896732489     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12132     Document Type: Article

References (19)

1. Davidson PC, Hebblewhite HR, Steed RD, et al. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008; 14: 1095-1101.
2. Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol 2010; 4: 1174-1181.
3. Bode BW. Insulin pump therapy. In: Lebovitz H (eds). Therapy for Diabetes Mellitus and Related Disorder, 4th edn. American Diabetes Association, Alexandria (VA), 2004; 224-231.
4. King AB. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring. Endocr Pract 2010; 16: 428-432.
5. Kuroda A, Yasuda T, Takahara M, et al. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump. Diabetes Technol Ther 2012; 14: 1077-1080.
6. Rabasa-Lhoret R, Garon J, Langelier H, et al. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care 1999; 22: 667-673.
7. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract 2005; 69: 14-21.
8. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program value. J Diabetes Invest 2012; 3: 39-40.
9. Kuroda A, Kaneto H, Yasuda T, et al. Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump. Diabetes Care 2011; 34: 1089-1890.
10. Diet Therapy. In: Japan Diabetes Society (eds). Treatment guide for Diabetes. Bunkodo, Tokyo, 2007, 34-36.
11. Hashimoto T, Kawamura T, Kashihara Y, et al. Factors associated with basal insulin dose in Japanese children and young adult type 1 diabetes. J Diabetes Invest 2012; 3: 276-282.
12. Taki K, Nishimura R, Morimoto A, et al. Analysis of 24-hour glycemic excursions in patients with type 1 diabetes by using continuous glucose monitoring. Diabetes Technol Ther 2010; 12: 523-528.
13. King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol 2007; 1: 36-41.
14. Bachran R, Beyer P, Klinkert C, et al. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 2012; 13: 1-5.
15. Campbell PJ, Bolli GB, Cryer PE, et al. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med 1985; 312: 1473-1479.
16. Williams RM, Amin R, Shojaee-Moradie F, et al. The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus. Diabetologia 2003; 46: 1203-1210.
17. Bolli GB, De Feo P, De Cosmo S, et al. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 1984; 33: 1150-1153.
18. Jovanovic A, Gerrard J, Taylor R. The second-meal phenomenon in type 2 diabetes. Diabetes Care 2009; 32: 1199-1201.
19. Jovanovic A, Leverton E, Solanky B, et al. The second-meal phenomenon is associated with enhanced muscle glycogen storage in humans. Clin Sci 2009; 117: 119-127.